To assess the potential of EVs as biomarkers of pancreatic cancer, we investigated the relative protein expression levels of four EV biomarkers (ITGαv, ITGβ5, GPC-1, and EpCAM) in EVs isolated from PDAC cell lines, mouse models, and patient plasma (Fig. 4). This evidence concerns the gene ITGAV and pancreatic neoplasm.